OBJECTIVE: To predict future medical expenditures, health care utilization, and mortality in Switzerland using an updated chronic disease score (CDS), a chronic morbidity measure based on pharmacy data. STUDY DESIGN AND SETTING: We performed a cohort study using medical claims data from insured persons enrolled in 2009 and 2010. Patient's characteristics, chronic conditions, and health care costs from baseline were used to calculate each patient's disease score. Two-part regression models were fit to predict health care expenditures, utilization, and mortality during the following year using the score's baseline values. We calculated the proportion of explained variation for each regression model to assess their performance. RESULTS: The CDS model, controlled for sociodemographics and health insurance plan, showed a significant improvement in explained variance of health care costs, outpatient costs, and outpatient visits in 2010. Future outpatient visits were predicted best with an R(2) of 29.2% (age group: 18-65 years) and 22.9% (>65 years), and models predicted future mortality with a c-statistic of 0.8. CONCLUSION: The CDS showed reasonable predictive validity of future health care utilization and medical expenditure based on pharmacy dispensing data, which may support health care decision makers in the planning delivery systems and resource allocation.
OBJECTIVE: To predict future medical expenditures, health care utilization, and mortality in Switzerland using an updated chronic disease score (CDS), a chronic morbidity measure based on pharmacy data. STUDY DESIGN AND SETTING: We performed a cohort study using medical claims data from insured persons enrolled in 2009 and 2010. Patient's characteristics, chronic conditions, and health care costs from baseline were used to calculate each patient's disease score. Two-part regression models were fit to predict health care expenditures, utilization, and mortality during the following year using the score's baseline values. We calculated the proportion of explained variation for each regression model to assess their performance. RESULTS: The CDS model, controlled for sociodemographics and health insurance plan, showed a significant improvement in explained variance of health care costs, outpatient costs, and outpatient visits in 2010. Future outpatient visits were predicted best with an R(2) of 29.2% (age group: 18-65 years) and 22.9% (>65 years), and models predicted future mortality with a c-statistic of 0.8. CONCLUSION: The CDS showed reasonable predictive validity of future health care utilization and medical expenditure based on pharmacy dispensing data, which may support health care decision makers in the planning delivery systems and resource allocation.
Authors: Marc Höglinger; Brigitte Wirth; Maria Carlander; Cornelia Caviglia; Christian Frei; Birgitta Rhomberg; Adrian Rohrbasser; Maria Trottmann; Klaus Eichler Journal: Eur J Health Econ Date: 2022-06-18
Authors: Claudia Schulz; Gisela Büchele; Raphael S Peter; Dietrich Rothenbacher; Christian Brettschneider; Ulrich C Liener; Clemens Becker; Kilian Rapp; Hans-Helmut König Journal: Eur J Health Econ Date: 2021-04-04
Authors: Dmitrij Achelrod; Carl Rudolf Blankart; Roland Linder; Yskert von Kodolitsch; Tom Stargardt Journal: Orphanet J Rare Dis Date: 2014-06-23 Impact factor: 4.123
Authors: Marie-Annick Le Pogam; Catherine Quantin; Oliver Reich; Philippe Tuppin; Anne Fagot-Campagna; Fred Paccaud; Isabelle Peytremann-Bridevaux; Bernard Burnand Journal: JMIR Res Protoc Date: 2017-05-11
Authors: Radoslaw Panczak; Xhyljeta Luta; Maud Maessen; Andreas E Stuck; Claudia Berlin; Kurt Schmidlin; Oliver Reich; Viktor von Wyl; David C Goodman; Matthias Egger; Marcel Zwahlen; Kerri M Clough-Gorr Journal: Med Care Date: 2017-02 Impact factor: 2.983